Search Videos and More
BREAST CANCER PROGRAM
Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship ServicesNational and International Accolades
Meet the bold clinicians and researchers whose work and perseverance push the edge of discovery, and have helped Fox Chase Cancer Center reach our 50th anniversary of excellence in cancer care.Fox Chase Cancer Center Appoints Dr. Jeffrey M. Farma Chair of Surgery
Fox Chase Cancer Center has appointed Jeffrey M. Farma, MD, FACS, to Chair of Surgery following a succession of leadership roles at the center.Fox Chase Cancer Center Opens First New Jersey Location in Voorhees
Fox Chase Cancer Center is proud to welcome patients to its newly opened office, which is located at 502 Centennial Boulevard, Suite 7, in Voorhees, New Jersey.Fox Chase Researcher and Former Chief Fellow Presents Findings on 5-Aminolevulinic Acid-Mediated Radiation Therapy to Reduce Tumor Size
“Radiodynamic therapy is a combined treatment technique of photodynamic therapy and radiation therapy that treats cancer using light and radiation,” said Dae-Myoung Yang, PhD, an Assistant Professor in the Department of Radiation Oncology at Fox Chase.A Prolific Career. An Auspicious Beginning.
As a genitourinary medical oncologist at Johns Hopkins, Jean Hoffman-Censits, MD, Associate Professor of Oncology and Urology, focuses on urothelial cancers of the bladder and upper tract, particularly women’s bladder cancer, which is often more aggressive than in men.Fox Chase Vision Illuminated by Real Nurses and Real Patients
When asked to present the keynote at this year’s ONA Summit, Real Nurses, Real Solutions: Breakthrough Strategies in Oncology Nursing Practice, Anna Liza Rodriguez, MSN, MHA, RN, OCN, NEA-BC, Chief Nursing Officer and Vice President, Nursing and Patient Care Services at Fox Chase Cancer Center, had the Fox Chase nursing staff, support staff, and patients bring the theme to life in a heartfelt video, demonstrating Fox Chase's vision and values.Temple University Hospital and Fox Chase Cancer Center Researchers Characterize HER2 Mutations in Patients With Lung Adenocarcinoma
Human epidermal growth factor 2 (HER2) mutations can be identified in up to 6% of non-small cell lung cancer cases where KRAS, EGFR, or ALK gene mutations are also found, according to the results of research from Temple University Hospital and Fox Chase Cancer Center presented today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.Fox Chase Researchers Present Data on Integrating Palliative Care Education Into Hematology-Oncology Fellowships
A new integrated palliative care rotation for hematology/oncology fellows improved their palliative care knowledge and skill confidence, according to results of a pilot study presented today by Fox Chase Cancer Center researchers at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.Putting the Nurse Back into Nurse Navigation
More than 15 years ago, Fox Chase Cancer Center launched a Nurse Navigation system to expedite the journey through complex cancer care with experienced oncologic nurses as a patient’s first 'point-of-contact' via phone.Harnessing the Power of Adaptive Radiation Therapy: A One-Year Review from Fox Chase Cancer Center
Over the past year, the Fox Chase Cancer Center Radiation Oncology team led by Eric Horwitz, MD, FABS, FASTRO, Chair of the Department of Radiation Oncology at Fox Chase and the Lewis Katz School of Medicine at Temple University, has boldly moved adaptive radiation therapy into the mainstream, demonstrating its clinical advantages for treating prostate, bladder, liver, pancreas, breast, lung, and head and neck cancers.Fox Chase Researcher’s Presentation Highlights Unique Approach to Esophagectomy at American College of Surgeons Clinical Congress
Nosayaba Enofe, MD, presented his experience with a unique minimally invasive hybrid approach to esophagectomy at the American College of Surgeons Clinical Congress.